nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Irinotecan—colon cancer	0.169	0.535	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—colon cancer	0.0895	0.283	CbGbCtD
Acetylcysteine—SLC22A6—Methotrexate—colon cancer	0.0576	0.182	CbGbCtD
Acetylcysteine—Palmar erythema—Capecitabine—colon cancer	0.0323	0.183	CcSEcCtD
Acetylcysteine—ACY1—renal system—colon cancer	0.00987	0.0724	CbGeAlD
Acetylcysteine—ACY1—digestive system—colon cancer	0.00809	0.0594	CbGeAlD
Acetylcysteine—CHUK—epithelium—colon cancer	0.00734	0.0539	CbGeAlD
Acetylcysteine—CHUK—renal system—colon cancer	0.00681	0.05	CbGeAlD
Acetylcysteine—IKBKB—embryo—colon cancer	0.00612	0.0449	CbGeAlD
Acetylcysteine—ACY1—liver—colon cancer	0.00603	0.0443	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—colon cancer	0.00583	0.0428	CbGeAlD
Acetylcysteine—CHUK—lymphoid tissue—colon cancer	0.00566	0.0415	CbGeAlD
Acetylcysteine—SLC7A11—renal system—colon cancer	0.00561	0.0412	CbGeAlD
Acetylcysteine—CHUK—digestive system—colon cancer	0.00559	0.041	CbGeAlD
Acetylcysteine—IKBKB—smooth muscle tissue—colon cancer	0.00481	0.0353	CbGeAlD
Acetylcysteine—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00473	0.0268	CcSEcCtD
Acetylcysteine—GSS—smooth muscle tissue—colon cancer	0.00472	0.0347	CbGeAlD
Acetylcysteine—Respiratory distress—Vincristine—colon cancer	0.00469	0.0266	CcSEcCtD
Acetylcysteine—SLC7A11—digestive system—colon cancer	0.0046	0.0338	CbGeAlD
Acetylcysteine—GSS—renal system—colon cancer	0.00454	0.0334	CbGeAlD
Acetylcysteine—CHUK—liver—colon cancer	0.00416	0.0306	CbGeAlD
Acetylcysteine—Chest tightness—Capecitabine—colon cancer	0.00415	0.0235	CcSEcCtD
Acetylcysteine—IKBKB—lymphoid tissue—colon cancer	0.00384	0.0282	CbGeAlD
Acetylcysteine—IKBKB—digestive system—colon cancer	0.0038	0.0279	CbGeAlD
Acetylcysteine—GRIN2A—vagina—colon cancer	0.00376	0.0276	CbGeAlD
Acetylcysteine—GSS—digestive system—colon cancer	0.00373	0.0274	CbGeAlD
Acetylcysteine—GSS—bone marrow—colon cancer	0.00344	0.0252	CbGeAlD
Acetylcysteine—IKBKB—vagina—colon cancer	0.00335	0.0246	CbGeAlD
Acetylcysteine—SLCO1B1—renal system—colon cancer	0.00334	0.0245	CbGeAlD
Acetylcysteine—GSS—vagina—colon cancer	0.00329	0.0242	CbGeAlD
Acetylcysteine—CHUK—lymph node—colon cancer	0.00319	0.0234	CbGeAlD
Acetylcysteine—Respiratory distress—Capecitabine—colon cancer	0.00306	0.0173	CcSEcCtD
Acetylcysteine—Gait disturbance—Vincristine—colon cancer	0.00306	0.0173	CcSEcCtD
Acetylcysteine—Gait disturbance—Irinotecan—colon cancer	0.00298	0.0168	CcSEcCtD
Acetylcysteine—IKBKB—liver—colon cancer	0.00283	0.0208	CbGeAlD
Acetylcysteine—GSS—liver—colon cancer	0.00278	0.0204	CbGeAlD
Acetylcysteine—SLCO1B1—digestive system—colon cancer	0.00274	0.0201	CbGeAlD
Acetylcysteine—Haemoptysis—Capecitabine—colon cancer	0.00263	0.0149	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Capecitabine—colon cancer	0.0024	0.0136	CcSEcCtD
Acetylcysteine—Chest discomfort—Capecitabine—colon cancer	0.0022	0.0124	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00218	0.0123	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—colon cancer	0.00217	0.0159	CbGeAlD
Acetylcysteine—GSS—lymph node—colon cancer	0.00213	0.0156	CbGeAlD
Acetylcysteine—SLCO1B1—liver—colon cancer	0.00204	0.015	CbGeAlD
Acetylcysteine—Gait disturbance—Capecitabine—colon cancer	0.00199	0.0113	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Fluorouracil—colon cancer	0.00181	0.0102	CcSEcCtD
Acetylcysteine—Mental disability—Capecitabine—colon cancer	0.00169	0.00954	CcSEcCtD
Acetylcysteine—Ear pain—Capecitabine—colon cancer	0.00165	0.00936	CcSEcCtD
Acetylcysteine—Stomatitis—Vincristine—colon cancer	0.00163	0.0092	CcSEcCtD
Acetylcysteine—Sweating—Vincristine—colon cancer	0.0016	0.00905	CcSEcCtD
Acetylcysteine—Stomatitis—Irinotecan—colon cancer	0.00158	0.00896	CcSEcCtD
Acetylcysteine—Eye pain—Capecitabine—colon cancer	0.00156	0.00884	CcSEcCtD
Acetylcysteine—Sweating—Irinotecan—colon cancer	0.00156	0.00881	CcSEcCtD
Acetylcysteine—Stomatitis—Fluorouracil—colon cancer	0.00152	0.00858	CcSEcCtD
Acetylcysteine—Cardiac disorder—Vincristine—colon cancer	0.00139	0.00786	CcSEcCtD
Acetylcysteine—Pharyngitis—Fluorouracil—colon cancer	0.00139	0.00784	CcSEcCtD
Acetylcysteine—Face oedema—Capecitabine—colon cancer	0.00136	0.00771	CcSEcCtD
Acetylcysteine—Angiopathy—Vincristine—colon cancer	0.00136	0.00769	CcSEcCtD
Acetylcysteine—Flushing—Irinotecan—colon cancer	0.00135	0.00766	CcSEcCtD
Acetylcysteine—Cardiac disorder—Irinotecan—colon cancer	0.00135	0.00766	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vincristine—colon cancer	0.00135	0.00764	CcSEcCtD
Acetylcysteine—Angiopathy—Irinotecan—colon cancer	0.00132	0.00749	CcSEcCtD
Acetylcysteine—Immune system disorder—Irinotecan—colon cancer	0.00132	0.00745	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Irinotecan—colon cancer	0.00131	0.00744	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Capecitabine—colon cancer	0.00126	0.00714	CcSEcCtD
Acetylcysteine—Asthma—Capecitabine—colon cancer	0.00122	0.0069	CcSEcCtD
Acetylcysteine—Erythema—Fluorouracil—colon cancer	0.00122	0.00688	CcSEcCtD
Acetylcysteine—Bronchospasm—Capecitabine—colon cancer	0.0012	0.00679	CcSEcCtD
Acetylcysteine—Syncope—Irinotecan—colon cancer	0.00114	0.00644	CcSEcCtD
Acetylcysteine—Loss of consciousness—Irinotecan—colon cancer	0.00112	0.00631	CcSEcCtD
Acetylcysteine—Cough—Irinotecan—colon cancer	0.00111	0.00627	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00109	0.00614	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vincristine—colon cancer	0.00106	0.00602	CcSEcCtD
Acetylcysteine—Oedema—Vincristine—colon cancer	0.00106	0.00602	CcSEcCtD
Acetylcysteine—Stomatitis—Capecitabine—colon cancer	0.00106	0.006	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Irinotecan—colon cancer	0.00104	0.00586	CcSEcCtD
Acetylcysteine—Oedema—Irinotecan—colon cancer	0.00104	0.00586	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Vincristine—colon cancer	0.00103	0.00582	CcSEcCtD
Acetylcysteine—Shock—Irinotecan—colon cancer	0.00102	0.00577	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Irinotecan—colon cancer	0.001	0.00567	CcSEcCtD
Acetylcysteine—Hypotension—Vincristine—colon cancer	0.000994	0.00563	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Fluorouracil—colon cancer	0.000992	0.00562	CcSEcCtD
Acetylcysteine—Oedema—Fluorouracil—colon cancer	0.000992	0.00562	CcSEcCtD
Acetylcysteine—Pharyngitis—Capecitabine—colon cancer	0.000969	0.00548	CcSEcCtD
Acetylcysteine—Tachycardia—Fluorouracil—colon cancer	0.000969	0.00548	CcSEcCtD
Acetylcysteine—Hypotension—Irinotecan—colon cancer	0.000968	0.00548	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—colon cancer	0.000927	0.00525	CcSEcCtD
Acetylcysteine—Dyspnoea—Irinotecan—colon cancer	0.000924	0.00523	CcSEcCtD
Acetylcysteine—Somnolence—Irinotecan—colon cancer	0.000921	0.00521	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vincristine—colon cancer	0.000919	0.0052	CcSEcCtD
Acetylcysteine—Dyspepsia—Irinotecan—colon cancer	0.000912	0.00516	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—colon cancer	0.000908	0.00514	CcSEcCtD
Acetylcysteine—Cardiac disorder—Capecitabine—colon cancer	0.000906	0.00513	CcSEcCtD
Acetylcysteine—Flushing—Capecitabine—colon cancer	0.000906	0.00513	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000895	0.00506	CcSEcCtD
Acetylcysteine—Angiopathy—Capecitabine—colon cancer	0.000886	0.00501	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—colon cancer	0.000885	0.00501	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—colon cancer	0.000882	0.00499	CcSEcCtD
Acetylcysteine—Immune system disorder—Capecitabine—colon cancer	0.000882	0.00499	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Capecitabine—colon cancer	0.00088	0.00498	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—colon cancer	0.000874	0.00494	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000857	0.00485	CcSEcCtD
Acetylcysteine—Erythema—Capecitabine—colon cancer	0.00085	0.00481	CcSEcCtD
Acetylcysteine—Body temperature increased—Vincristine—colon cancer	0.000841	0.00476	CcSEcCtD
Acetylcysteine—Body temperature increased—Irinotecan—colon cancer	0.000819	0.00463	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—colon cancer	0.000809	0.00458	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—colon cancer	0.000789	0.00446	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—colon cancer	0.000788	0.00446	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—colon cancer	0.000785	0.00444	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vincristine—colon cancer	0.000784	0.00444	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—colon cancer	0.000776	0.00439	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irinotecan—colon cancer	0.000763	0.00432	CcSEcCtD
Acetylcysteine—Syncope—Capecitabine—colon cancer	0.000762	0.00431	CcSEcCtD
Acetylcysteine—Loss of consciousness—Capecitabine—colon cancer	0.000747	0.00423	CcSEcCtD
Acetylcysteine—Cough—Capecitabine—colon cancer	0.000742	0.0042	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—colon cancer	0.000731	0.00414	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—colon cancer	0.000721	0.00408	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000718	0.00407	CcSEcCtD
Acetylcysteine—Dizziness—Vincristine—colon cancer	0.000704	0.00398	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—colon cancer	0.000702	0.00397	CcSEcCtD
Acetylcysteine—Oedema—Capecitabine—colon cancer	0.000694	0.00392	CcSEcCtD
Acetylcysteine—Dizziness—Irinotecan—colon cancer	0.000685	0.00388	CcSEcCtD
Acetylcysteine—Shock—Capecitabine—colon cancer	0.000682	0.00386	CcSEcCtD
Acetylcysteine—Tachycardia—Capecitabine—colon cancer	0.000677	0.00383	CcSEcCtD
Acetylcysteine—Vomiting—Vincristine—colon cancer	0.000676	0.00383	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—colon cancer	0.000674	0.00382	CcSEcCtD
Acetylcysteine—Skin disorder—Capecitabine—colon cancer	0.000674	0.00381	CcSEcCtD
Acetylcysteine—Rash—Vincristine—colon cancer	0.000671	0.0038	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Capecitabine—colon cancer	0.00067	0.00379	CcSEcCtD
Acetylcysteine—Dermatitis—Vincristine—colon cancer	0.00067	0.00379	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—colon cancer	0.000659	0.00373	CcSEcCtD
Acetylcysteine—Vomiting—Irinotecan—colon cancer	0.000659	0.00373	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—colon cancer	0.000656	0.00371	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—colon cancer	0.000656	0.00371	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—colon cancer	0.000655	0.00371	CcSEcCtD
Acetylcysteine—Rash—Irinotecan—colon cancer	0.000653	0.0037	CcSEcCtD
Acetylcysteine—Dermatitis—Irinotecan—colon cancer	0.000653	0.00369	CcSEcCtD
Acetylcysteine—Hypotension—Capecitabine—colon cancer	0.000648	0.00367	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—colon cancer	0.000633	0.00358	CcSEcCtD
Acetylcysteine—Nausea—Vincristine—colon cancer	0.000632	0.00358	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—colon cancer	0.000631	0.00357	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—colon cancer	0.000626	0.00354	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—colon cancer	0.000625	0.00354	CcSEcCtD
Acetylcysteine—Dyspnoea—Capecitabine—colon cancer	0.000618	0.0035	CcSEcCtD
Acetylcysteine—Nausea—Irinotecan—colon cancer	0.000615	0.00348	CcSEcCtD
Acetylcysteine—Dyspepsia—Capecitabine—colon cancer	0.00061	0.00345	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000599	0.00339	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—colon cancer	0.000589	0.00334	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—colon cancer	0.000552	0.00312	CcSEcCtD
Acetylcysteine—Urticaria—Capecitabine—colon cancer	0.000551	0.00312	CcSEcCtD
Acetylcysteine—Body temperature increased—Capecitabine—colon cancer	0.000548	0.0031	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000535	0.00303	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—colon cancer	0.000516	0.00292	CcSEcCtD
Acetylcysteine—Hypersensitivity—Capecitabine—colon cancer	0.000511	0.00289	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—colon cancer	0.000501	0.00284	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—colon cancer	0.000499	0.00282	CcSEcCtD
Acetylcysteine—Pruritus—Capecitabine—colon cancer	0.000491	0.00278	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—colon cancer	0.000482	0.00273	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—colon cancer	0.00046	0.0026	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—colon cancer	0.000459	0.0026	CcSEcCtD
Acetylcysteine—Dizziness—Capecitabine—colon cancer	0.000459	0.00259	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—colon cancer	0.000454	0.00257	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000446	0.00252	CcSEcCtD
Acetylcysteine—Vomiting—Capecitabine—colon cancer	0.000441	0.00249	CcSEcCtD
Acetylcysteine—Rash—Capecitabine—colon cancer	0.000437	0.00247	CcSEcCtD
Acetylcysteine—Dermatitis—Capecitabine—colon cancer	0.000437	0.00247	CcSEcCtD
Acetylcysteine—Nausea—Capecitabine—colon cancer	0.000412	0.00233	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—colon cancer	0.00041	0.00232	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—colon cancer	0.000408	0.00231	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—colon cancer	0.00038	0.00215	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—colon cancer	0.000365	0.00207	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—colon cancer	0.000341	0.00193	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—colon cancer	0.000328	0.00186	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—colon cancer	0.000326	0.00184	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—colon cancer	0.000325	0.00184	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—colon cancer	0.000307	0.00174	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—AKT1—colon cancer	0.00013	0.000352	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—PIK3CA—colon cancer	0.00013	0.000351	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	0.000129	0.000348	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—CDKN1A—colon cancer	0.000129	0.000348	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KRAS—colon cancer	0.000129	0.000347	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—EGFR—colon cancer	0.000129	0.000347	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD8A—colon cancer	0.000128	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	0.000128	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—AKT1—colon cancer	0.000128	0.000346	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—colon cancer	0.000127	0.000341	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—colon cancer	0.000126	0.000341	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL2L1—colon cancer	0.000126	0.00034	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—CTNNB1—colon cancer	0.000126	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000125	0.000338	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—AKT1—colon cancer	0.000125	0.000337	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—CASP3—colon cancer	0.000124	0.000335	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000124	0.000334	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000124	0.000333	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—colon cancer	0.000123	0.000333	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—PIK3CA—colon cancer	0.000123	0.000332	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—PIK3CA—colon cancer	0.000123	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—colon cancer	0.000123	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—colon cancer	0.000123	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	0.000123	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—AKT1—colon cancer	0.000123	0.000331	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—CTNNB1—colon cancer	0.000123	0.000331	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—colon cancer	0.000122	0.000329	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—colon cancer	0.000122	0.000328	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—colon cancer	0.000122	0.000328	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000121	0.000327	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—colon cancer	0.000121	0.000327	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—colon cancer	0.000121	0.000326	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—colon cancer	0.000121	0.000326	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FGFR3—colon cancer	0.000121	0.000325	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—colon cancer	0.00012	0.000325	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.00012	0.000323	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—SRC—colon cancer	0.000119	0.000322	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—colon cancer	0.000119	0.000321	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	0.000118	0.000318	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—AKT1—colon cancer	0.000117	0.000316	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EP300—colon cancer	0.000117	0.000316	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	0.000117	0.000316	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—CDKN1A—colon cancer	0.000117	0.000315	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—AKT1—colon cancer	0.000117	0.000315	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—colon cancer	0.000117	0.000315	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—AKT1—colon cancer	0.000116	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—AKT1—colon cancer	0.000116	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FGFR3—colon cancer	0.000116	0.000312	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—AKT1—colon cancer	0.000116	0.000312	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—colon cancer	0.000115	0.000309	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2L1—colon cancer	0.000114	0.000309	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EP300—colon cancer	0.000114	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—colon cancer	0.000114	0.000307	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—colon cancer	0.000114	0.000307	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	0.000114	0.000307	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—SRC—colon cancer	0.000114	0.000307	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—colon cancer	0.000112	0.000303	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PIK3CA—colon cancer	0.000112	0.000302	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—PIK3CA—colon cancer	0.000112	0.000301	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	0.000112	0.000301	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—SRC—colon cancer	0.000111	0.000299	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—colon cancer	0.000111	0.000299	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—colon cancer	0.00011	0.000295	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—colon cancer	0.000109	0.000295	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FGFR3—colon cancer	0.000109	0.000295	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.000109	0.000294	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	0.000109	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—AKT1—colon cancer	0.000109	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—AKT1—colon cancer	0.000109	0.000293	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—SRC—colon cancer	0.000108	0.000292	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—colon cancer	0.000108	0.000292	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—AKT1—colon cancer	0.000108	0.000291	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—AKT1—colon cancer	0.000107	0.000288	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000107	0.000288	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—colon cancer	0.000107	0.000288	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—colon cancer	0.000106	0.000287	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—colon cancer	0.000106	0.000285	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FGFR3—colon cancer	0.000105	0.000283	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—EGFR—colon cancer	0.000104	0.000282	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—colon cancer	0.000104	0.000282	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—colon cancer	0.000104	0.000281	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—colon cancer	0.000103	0.000279	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	0.000103	0.000279	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—colon cancer	0.000103	0.000277	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000102	0.000276	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TGFB1—colon cancer	0.000102	0.000274	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—colon cancer	0.000101	0.000271	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—colon cancer	0.000101	0.000271	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—colon cancer	0.0001	0.000271	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EGFR—colon cancer	9.98e-05	0.000269	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TGFB1—colon cancer	9.92e-05	0.000268	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—colon cancer	9.87e-05	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	9.86e-05	0.000266	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDH1—colon cancer	9.79e-05	0.000264	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—colon cancer	9.73e-05	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	9.63e-05	0.00026	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—colon cancer	9.48e-05	0.000256	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—colon cancer	9.43e-05	0.000254	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—colon cancer	9.22e-05	0.000249	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—colon cancer	9.19e-05	0.000248	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—colon cancer	9.14e-05	0.000246	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—colon cancer	9.13e-05	0.000246	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—colon cancer	9.1e-05	0.000246	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—colon cancer	9.07e-05	0.000245	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.07e-05	0.000245	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—colon cancer	8.95e-05	0.000241	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—colon cancer	8.87e-05	0.000239	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—EP300—colon cancer	8.68e-05	0.000234	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—colon cancer	8.59e-05	0.000232	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—colon cancer	8.53e-05	0.00023	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—colon cancer	8.39e-05	0.000226	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—colon cancer	8.36e-05	0.000226	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—colon cancer	8.22e-05	0.000222	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—colon cancer	8.01e-05	0.000216	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—colon cancer	7.81e-05	0.000211	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—colon cancer	7.79e-05	0.00021	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—colon cancer	7.74e-05	0.000209	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—colon cancer	7.61e-05	0.000205	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—colon cancer	7.52e-05	0.000203	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—colon cancer	7.41e-05	0.0002	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1A—colon cancer	7.35e-05	0.000198	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—colon cancer	7.35e-05	0.000198	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.13e-05	0.000192	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—colon cancer	7.07e-05	0.000191	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1A—colon cancer	7.06e-05	0.00019	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGFR3—colon cancer	7.03e-05	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EP300—colon cancer	6.99e-05	0.000189	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—colon cancer	6.9e-05	0.000186	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—colon cancer	6.82e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—colon cancer	6.8e-05	0.000183	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—colon cancer	6.72e-05	0.000181	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1A—colon cancer	6.66e-05	0.00018	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—colon cancer	6.66e-05	0.00018	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—colon cancer	6.54e-05	0.000176	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—colon cancer	6.53e-05	0.000176	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGFR3—colon cancer	6.49e-05	0.000175	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—colon cancer	6.42e-05	0.000173	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1A—colon cancer	6.4e-05	0.000173	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGFR3—colon cancer	6.37e-05	0.000172	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EP300—colon cancer	6.34e-05	0.000171	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—colon cancer	6.28e-05	0.000169	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—colon cancer	6.17e-05	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—colon cancer	5.96e-05	0.000161	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APC—colon cancer	5.96e-05	0.000161	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—colon cancer	5.94e-05	0.00016	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—colon cancer	5.93e-05	0.00016	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.93e-05	0.00016	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—colon cancer	5.92e-05	0.00016	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCB1—colon cancer	5.8e-05	0.000157	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—colon cancer	5.72e-05	0.000154	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—colon cancer	5.7e-05	0.000154	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—colon cancer	5.7e-05	0.000154	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—colon cancer	5.63e-05	0.000152	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—colon cancer	5.6e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—colon cancer	5.41e-05	0.000146	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—colon cancer	5.4e-05	0.000146	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—colon cancer	5.38e-05	0.000145	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—colon cancer	5.25e-05	0.000142	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—colon cancer	5.19e-05	0.00014	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—colon cancer	5.17e-05	0.00014	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—colon cancer	5.11e-05	0.000138	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—colon cancer	4.97e-05	0.000134	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—colon cancer	4.9e-05	0.000132	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—colon cancer	4.79e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—colon cancer	4.69e-05	0.000127	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—colon cancer	4.6e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR3—colon cancer	4.54e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—colon cancer	4.52e-05	0.000122	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—colon cancer	4.5e-05	0.000121	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.39e-05	0.000118	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—colon cancer	4.38e-05	0.000118	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—colon cancer	4.34e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—colon cancer	4.28e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—colon cancer	4.23e-05	0.000114	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—colon cancer	4.17e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—colon cancer	4.17e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR3—colon cancer	4.12e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—colon cancer	4.07e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—colon cancer	4.06e-05	0.000109	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—colon cancer	4.05e-05	0.000109	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—colon cancer	4.04e-05	0.000109	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—colon cancer	3.97e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—colon cancer	3.96e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—colon cancer	3.95e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—colon cancer	3.92e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—colon cancer	3.88e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—colon cancer	3.83e-05	0.000103	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—colon cancer	3.81e-05	0.000103	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—colon cancer	3.78e-05	0.000102	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—colon cancer	3.76e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—colon cancer	3.69e-05	9.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—colon cancer	3.68e-05	9.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—colon cancer	3.66e-05	9.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—colon cancer	3.59e-05	9.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—colon cancer	3.55e-05	9.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—colon cancer	3.52e-05	9.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—colon cancer	3.47e-05	9.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—colon cancer	3.46e-05	9.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—colon cancer	3.28e-05	8.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—colon cancer	3.28e-05	8.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—colon cancer	3.27e-05	8.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—colon cancer	3.21e-05	8.64e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—colon cancer	3.18e-05	8.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—colon cancer	3.15e-05	8.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—colon cancer	3.03e-05	8.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—colon cancer	3.01e-05	8.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—colon cancer	2.97e-05	8.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—colon cancer	2.94e-05	7.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—colon cancer	2.86e-05	7.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—colon cancer	2.83e-05	7.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—colon cancer	2.79e-05	7.52e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—colon cancer	2.78e-05	7.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—colon cancer	2.77e-05	7.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—colon cancer	2.73e-05	7.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—colon cancer	2.67e-05	7.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—colon cancer	2.64e-05	7.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—colon cancer	2.63e-05	7.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—colon cancer	2.59e-05	7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—colon cancer	2.57e-05	6.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—colon cancer	2.57e-05	6.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—colon cancer	2.56e-05	6.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—colon cancer	2.53e-05	6.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—colon cancer	2.51e-05	6.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—colon cancer	2.49e-05	6.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—colon cancer	2.46e-05	6.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—colon cancer	2.46e-05	6.64e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—colon cancer	2.39e-05	6.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—colon cancer	2.32e-05	6.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—colon cancer	2.29e-05	6.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—colon cancer	2.29e-05	6.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—colon cancer	2.27e-05	6.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—colon cancer	2.26e-05	6.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—colon cancer	2.24e-05	6.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—colon cancer	2.23e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—colon cancer	2.23e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—colon cancer	2.12e-05	5.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—colon cancer	2.08e-05	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—colon cancer	2.08e-05	5.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—colon cancer	2.04e-05	5.49e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—colon cancer	1.95e-05	5.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—colon cancer	1.95e-05	5.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—colon cancer	1.92e-05	5.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—colon cancer	1.88e-05	5.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—colon cancer	1.8e-05	4.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—colon cancer	1.77e-05	4.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—colon cancer	1.71e-05	4.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—colon cancer	1.63e-05	4.41e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—colon cancer	1.6e-05	4.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—colon cancer	1.59e-05	4.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—colon cancer	1.44e-05	3.89e-05	CbGpPWpGaD
